Loading publications…
The last 5 uploaded publications
Heparin-Coated Palmaz-Schatz Stents in Human Coronary Arteries
Patrick W. Serruys, Håkan Emanuelsson, Wim van der Giessen, Anthony C. Lunn, Ferdinand Kiemeney, Carlos Macaya, Wolfgang Rutsch, Guy R. Heyndrickx, Harry Suryapranata, Victor Legrand, J J Goy, Pierre Materne, Hans Bonnier, Marie‐Claude Morice, Jean Fajadet, Jorge Belardi, Antonio Colombo, Eulogio Garcı́a, Peter Ruygrok, Peter de Jaegere, Marie‐Angèle Morel (1996). Heparin-Coated Palmaz-Schatz Stents in Human Coronary Arteries. Circulation, 93(3), pp. 412-422, DOI: 10.1161/01.cir.93.3.412.
Article147 days agoContinued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial
Ferdinand Kiemeneij, Patrick W. Serruys, Carlos Macaya, Wolfgang Rutsch, Guy R. Heyndrickx, Per Albertsson, Jean Fajadet, Victor Legrand, Pierre Materne, Jorge Belardi, Ulrich Sigwart, Antonio Colombo, Jean‐Jácques Goy, Clemens Disco, Marie-Angèle Morel (2001). Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. Journal of the American College of Cardiology, 37(6), pp. 1598-1603, DOI: 10.1016/s0735-1097(01)01207-4.
Article147 days agoPrevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT).
Patrick W. Serruys, Wolfgang Rutsch, Guy R. Heyndrickx, Nicolas Danchin, E. Gijs Mast, William Wijns, Benno J. Rensing, J. Cornelis de Vos, J. Stibbe (1991). Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT).. Circulation, 84(4), pp. 1568-1580, DOI: 10.1161/01.cir.84.4.1568.
Article147 days agoLuminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.
Benno J. Rensing, Walter Hermans, J. Cornelis de Vos, Jan G.P. Tijssen, W Rutch, Nicolas Danchin, Guy R. Heyndrickx, E. Gijs Mast, William Wijns, Patrick W. Serruys (1993). Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.. Circulation, 88(3), pp. 975-985, DOI: 10.1161/01.cir.88.3.975.
Article147 days agoDirectional atherectomy for treatment of restenosis within coronary stents: Clinical, angiographic and histologic results
Bradley H. Strauss, Victor A. Umans, Robert-Jan van Suylen, Pim J. de Feyter, Jean Marco, Gregory Robertson, Jean Renkin, Guy R. Heyndrickx, Vojislav D. Vuzevski, Fred T. Bosman, Patrick W. Serruys (1992). Directional atherectomy for treatment of restenosis within coronary stents: Clinical, angiographic and histologic results. Journal of the American College of Cardiology, 20(7), pp. 1465-1473, DOI: 10.1016/0735-1097(92)90438-s.
Article147 days ago